2015-09: a Phase II Randomized, Open-label Study of Anti-signaling Lymphocytic Activation Molecule Monoclonal Antibody During Maintenance Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane
- Status
- TERMINATED
- Phase
- NA
The Effects of Dexamethasone Administration on Jaundice Following Liver Resection
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Intraoperative Methadone Administration for Improved Pain Control in Spinal Fusion Patients
- Status
- TERMINATED
- Phase
- PHASE4
OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis
- Status
- COMPLETED
- Phase
- PHASE3
The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.
- Status
- UNKNOWN
- Phase
- PHASE3
Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department
- Status
- TERMINATED
- Phase
- PHASE4
Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Optimal Timing of Intercostal Nerve Blocks During Video-Assisted Thoracic Surgeries
- Status
- COMPLETED
- Phase
- PHASE4
Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment
- Status
- COMPLETED
- Phase
- PHASE2
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)
- Status
- UNKNOWN
- Phase
- PHASE1